Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H25NO4.ClH |
Molecular Weight | 391.888 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@]12CC3=C(CN1CCC4=CC(OC)=C(OC)C=C24)C(OC)=C(OC)C=C3
InChI
InChIKey=MGSZZQQRTPWMEI-UNTBIKODSA-N
InChI=1S/C21H25NO4.ClH/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4;/h5-6,10-11,17H,7-9,12H2,1-4H3;1H/t17-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C21H25NO4 |
Molecular Weight | 355.4275 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
TETRAHYDROPALMATINE, (+)- is an alkaloid found in the plants of the Carydalis species. Tetrahydropalmatine (THP) has two enantiomers with different effects on the brain dopaminergic system. Dopamine (DA) content reduction in the rat striatum induced by d-THP is much more dose-dependent. At a small dose, d-THP predominantly reduced the DA level but left serotonin and noradrenaline level unaffected. d-THP is probably a DA depletor. There were stereoselective differences between the two THP enantiomers on the activity of cytochrome P450 (CYP450) isozymes, i.e., d-THP had the potential to inhibit the activities of CYP2D6 and CYP1A2 isozymes, while l-THP inhibited CYP1A2 isozyme and induced CYP3A4 and CYP2C9 isozymes. The plasma levels of l-THP were always higher than those of d-THP in rats.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5685 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23831208 |
13.9 µM [IC50] | ||
Target ID: CHEMBL2304403 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26032585 |
|||
Target ID: CHEMBL1075125 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26032585 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Different effects of enantiomers of tetrahydropalmatine on dopaminergic system. | 1986 Oct |
|
[Brain dopamine depleted by d-tetrahydropalmatine]. | 1987 May |
|
Evaluation of Tetrahydropalmatine Enantiomers on the Activity of Five Cytochrome P450 Isozymes in Rats Using a Liquid Chromatography / Mass Spectrometric Method and a Cocktail Approach. | 2015 Aug |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2444064
Mice: 10 mg/kg
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2883726
d-THP hadn't an affinity to the rat dopamine receptor even at concentrations higher than 100 or 1000 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:18:54 GMT 2023
by
admin
on
Sat Dec 16 08:18:54 GMT 2023
|
Record UNII |
3W2KMH3XL9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3W2KMH3XL9
Created by
admin on Sat Dec 16 08:18:54 GMT 2023 , Edited by admin on Sat Dec 16 08:18:54 GMT 2023
|
PRIMARY | |||
|
23615997
Created by
admin on Sat Dec 16 08:18:54 GMT 2023 , Edited by admin on Sat Dec 16 08:18:54 GMT 2023
|
PRIMARY | |||
|
132058
Created by
admin on Sat Dec 16 08:18:54 GMT 2023 , Edited by admin on Sat Dec 16 08:18:54 GMT 2023
|
PRIMARY | |||
|
6024-83-5
Created by
admin on Sat Dec 16 08:18:54 GMT 2023 , Edited by admin on Sat Dec 16 08:18:54 GMT 2023
|
PRIMARY |